Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$114.52 -0.66 | -0.57%
10/05/15 - 04:14 PM ET
Company Profile
Price and Volume
Recent Price 115.18
52 Week High 143.45
52 Week Low 96.43
Avg. Daily Vol. (Mil) 1.93
Beta (3 year) 1.42
Share Related Items
Mkt Cap (Mil) 28,179.42
Shares Out (Mil) 244.66
Float (Mil) 217.59
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.00
Current Ratio 3.50
LT Debt/ Equity 0.86
Total Debt / Equity 0.92
Valuation Ratios
Price Earnings n.a.
Price/Sales 44.86
Price/Book 31.49
Price/Cash Flow -39.90
Per Share Data
Earnings -3.07
Sales 2.57
Book Value 3.66
Cash Flow -2.89
Business Summary
Vertex Pharmaceuticals Incis engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.
General Information
50 Northern Avenue
Boston, MA 02210
Industry : Drugs
Sector: Health Care
Employees: 1830
CEO: Dr. Jeffrey M Leiden M.D
Short Interest
Current Month (Mil) 5.69
Previous Month (Mil) 4.56
Short Interest Ratio (Days) 3.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -32.50
Return on Investments -46.30
Gross Margin 90.90
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter